Africa's Cancer Research Company

We use cutting edge immunogenomics, bioinformatics and artificial intelligence to accelerate the development of cancer detection and cure strategies, ultimately with the goal of lowering the economic burden of cancer on the African continent.

Learn More

What We Do

We are focused on improving cancer care through greater understanding of human genetic diversity.

Knowledge Base

Together with our clinical partners, we generate knowledge around cancer in African populations through our first-of-its-kind Pan-African digital genomic and clinical knowledge base.

Novel Solutions

We partner with pharmaceutical and biotechnology companies to develop the next generation of molecular diagnostics and therapeutics that overcome the challenges of genetic variations and are highly effective across different ethnicities.

Clinical Testing

Affordable, fully accredited molecular cancer testing services. This includes NGS-based screening and prognostic testing.

About Us

Our Mission

Our mission is to redefine how cancer is diagnosed and treated in Africa, through innovative, sustainable biomedical research and partnerships that aid in the advancement of medicine across the continent. This includes:

Optimise existing molecular diagnostic and prognostic tests for African populations and provide these as part of screening service.
Identify novel biomarkers for early detection of cancer among African populations and develop novel diagnostic tools based on these markers.
Engage with local community to promote cancer awareness, stressing the importance of early detection and providing education on the utility of molecular (genomic) techniques in aiding in the diagnosis and prognosis of cancer.
Accelerate adoption of personalised medicine among African population.

Our Team

Passion. Talent. Committment.

Dr. Yaw Bediako

CEO & Founder

Yaw is founder and CEO of Yemaachi Inc. With a PhD in Immunology (Northwestern University), Yaw has extensive expertise in cellular and molecular immunology, with research experience using both animal models and human cohorts.

Dr. Lily Paemka

Human Genetics

Lily is a molecular geneticist with expertise in characterising the roles of both complex and Mendelian human genetic traits in mediating disease. Research projects include risk factors for breast cancer in African women. She is a member of the American Society of Human Genetics.

Dr. Abdoulaye Diallo

BioInformatics & Machine Learning

Abdoulaye holds a Ph.D. degree in computer science (McGill University). He is a former research associate at the Broad Institute and postdoctoral scholar at the Computer Science and Artificial Intelligence Laboratory at MIT.

Joyce Ngoi

Head of Technical Services & Co-Founder

Joyce is a molecular biologist and next generation sequencing (NGS) technologist. She has expert knowledge of different NGS platforms and has extensive experience running and managing NGS research facilities.

Dr. Nelson Kibinge

Computational Biology

Nelson is a computational biologist with extensive experience in both academic and pharmaceutical sectors. He develops applications for genomics, transcriptomics, proteomics and metabolomics data mining.

Dr. Emmanuella Amoako

Paediatric Oncology

Ella is a paediatric oncology fellow with a keen interest in oncogenetics. She is interested in developing ways to deliver world-class cancer care in resource limited settings.

Yaw Attua-Afari

Finance & Co-Founder

Yaw is an investment professional with over 10 years’ experience in private equity, investment banking, project development and strategy in developed & emerging markets.

Aida Manu

Operations

Aida is a project management professional with over 10 years of success in clinical research, education, youth entrepreneurship, and social & market research.

David Hutchful

Technology & Co-Founder

With over 20 years experience in design and software development, David has created award-winning, innovative platforms in the areas of Finance, Agriculture and Health.

Jennifer MacBruce

Business Development

Jen works in investment management with over 15 years in asset management, investment analysis, product development and wealth management. Her expertise includes aligning innovation & new product investment decisions with corporate strategic growth.